Disclosure Of Interests In Other Entities [Text Block]

ERYTECH Pharma S.A. - Filing #858938

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2019-12-31
Disclosure of interests in other entities [text block]
Disclosure of interests in subsidiaries [text block]
Disclosure of subsidiaries [text block]
Principes de consolidation
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Current assets
42 634 EUR
40 048 EUR
49 632 EUR
Non-current assets
3 177 EUR
26 720 EUR
30 770 EUR
Current liabilities
11 678 EUR
20 005 EUR
29 347 EUR
Non-current liabilities
10 646 EUR
23 918 EUR
24 516 EUR
Profit (loss)
228,000 EUR
228,000 EUR
53 797 EUR
53 797 EUR
73 300 EUR
73 300 EUR
Comprehensive income
EUR
194,000 EUR
235,000 EUR
228,000 EUR
EUR
187,000 EUR
53 797 EUR
EUR
68,000 EUR
528,000 EUR
EUR
54 257 EUR
72 919 EUR
19,000 EUR
73 300 EUR
EUR
400,000 EUR
EUR
Disclosure of interests in associates [text block]
Disclosure of associates [text block]
Disclosure of associates [abstract]
Disclosure of associates [line items]
Other comprehensive income
422,000 EUR
235,000 EUR
EUR
187,000 EUR
68,000 EUR
528,000 EUR
460,000 EUR
381,000 EUR
19,000 EUR
400,000 EUR
Disclosure of interests in joint arrangements [text block]
Disclosure of joint ventures [text block]
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents
38 789 EUR
33 699 EUR
44 446 EUR
73 173 EUR
Tax expense (income)
521,000 EUR
2,000 EUR
3,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.